Fig. 7.
![Fig. 7. CD44 MoAbs and CD44-Rg inhibit CSB-induced PBMC proliferation. PBMC were incubated with CSB (1 mg/mL) with or without either the CD44 MoAb A3D8 (10 μg/mL; A), or CD44-Rg fusion protein (12 mg/mL ; B) for 6 days. [3H]-thymidine incorporation was measured in the last 16 hours of the experiment. The data were confirmed in three independent experiments.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/92/1/10.1182_blood.v92.1.223.413k15_223_229/5/blod41315007x.jpeg?Expires=1735526376&Signature=jSszQTz8noNn-YebmLMKHhf1gybPTCh2X1EkmCpxYgoLCpTfi7jGRxjpAk5aPajr4Bq72QvBZo5F-3P1gMkHA5bZgBiO6g4YvXWDilFBMWrtIhGqUUA0RPZ~sNlvKgmlFECyfbxJiwR~6yLcZYhL~TUJKwN~PnrZgXZ5YJCPk4EOuwmXfVHbg9GE81O3w2gQKHRhQQZnf~5nlmcVCZksfDh7iFmB3kG3fWOVzIFF0gZmNn5YwW0BGVSP260nbfnmfCIE8ETRHn1yBLj48k8hJGjR1LS6sWLZm5xGMUblJbCtpqiFlCtLyJv7Wtywop30~MGyz0ip3dmyG54vDBBrEw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
CD44 MoAbs and CD44-Rg inhibit CSB-induced PBMC proliferation. PBMC were incubated with CSB (1 mg/mL) with or without either the CD44 MoAb A3D8 (10 μg/mL; A), or CD44-Rg fusion protein (12 mg/mL ; B) for 6 days. [3H]-thymidine incorporation was measured in the last 16 hours of the experiment. The data were confirmed in three independent experiments.
